• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form POSASR filed by Chewy Inc.

    9/19/24 4:34:52 PM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary
    Get the next $CHWY alert in real time by email
    POSASR 1 d820996dposasr.htm POSASR POSASR

    As filed with the Securities and Exchange Commission on September 19, 2024.

    Registration No. 333-274535

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    POST-EFFECTIVE AMENDMENT NO. 1

    TO

    FORM S-3

    REGISTRATION STATEMENT

    UNDER

    THE SECURITIES ACT OF 1933

     

     

    Chewy, Inc.

    (Exact name of registrant as specified in its charter)

     

     

     

    Delaware   90-1020167

    (State or other jurisdiction of

    incorporation or organization)

     

    (I.R.S. Employer

    Identification No.)

    7700 West Sunrise Boulevard

    Plantation, Florida 33322

    (786) 320-7111

    (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

     

     

    Sumit Singh

    Chief Executive Officer

    7700 West Sunrise Boulevard

    Plantation, Florida 33322

    (786) 320-7111

    (Name, address, including zip code, and telephone number, including area code, of agent for service)

     

     

    Copies of all communications, including communications sent to agent for service, should be sent to:

    Joshua N. Korff

    Asher Qazi

    Kirkland & Ellis LLP

    601 Lexington Avenue

    New York, New York 10022

    (212) 446-4800

     

     

    Approximate date of commencement of proposed sale to the public:

    From time to time after the effective date of this registration statement.

     

     

    If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. ☐

    If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box. ☒

    If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

    If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

    If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the SEC pursuant to Rule 462(e) under the Securities Act, check the following box. ☒

    If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. ☐

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

    Large accelerated filer   ☒    Accelerated filer   ☐
    Non-accelerated filer   ☐    Smaller reporting company   ☐
         Emerging growth company   ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

     

     

     


    EXPLANATORY NOTE

    Chewy, Inc. (the “Company”) is filing this Post-Effective Amendment No. 1 (“Amendment No. 1”) to the Registration Statement on Form S-3 (Registration No. 333-274535), that was automatically effective upon its filing with the Securities and Exchange Commission (the “SEC”) on September 15, 2023 (the “Registration Statement”), to replace Exhibit 23.1 of Part II of the Registration Statement. This Amendment No. 1 consists only of the facing page, this explanatory note, and Part II of the Registration Statement. No other changes or additions are being made hereby to the prospectus constituting Part I of the Registration Statement. Accordingly, the prospectus constituting Part I of the Registration Statement has been omitted. Pursuant to Rule 462(d) under the Securities Act of 1933, as amended, this Amendment shall become effective immediately upon filing with the SEC.

    PART II

    INFORMATION NOT REQUIRED IN PROSPECTUS

    Item 14. Other Expenses of Issuance and Distribution

    The following table sets forth the fees and expenses in connection with the issuance and distribution of the securities being registered. All amounts are estimates.

     

    SEC registration fee

       $  (1)(2)  

    FINRA filing fee

       $ (2)  

    NYSE filing fee

       $ (2)  

    Accounting fees and expenses

       $ (2)  

    Legal fees and expenses

       $ (2)  

    Accounting fees and expenses

       $ (2)  

    Rating agency Fees

       $ (2)  

    Printing expenses

       $ (2)  

    Transfer agent, depositary and registrar fees and expenses

       $ (2)  

    Miscellaneous expenses

       $ (2)  
      

     

     

     

    Total

       $ (2)  
      

     

     

     

     

    (1)

    Under SEC Rules 456(b) and 457(r), the SEC registration fee will be paid at the time of any particular offering of securities under this registration statement, and is therefore not currently determinable.

    (2)

    The amount of these expenses is not currently known.

    Item 15. Indemnification of Directors and Officers

    Section 102(b)(7) of the DGCL permits a corporation to provide in its certificate of incorporation that a director or officer of the corporation shall not be personally liable to the corporation or its stockholders for monetary damages for breach of fiduciary duty as a director or officer except for: (i) a director or officer for any breach of the director’s or officer’s duty of loyalty to the corporation or its stockholders; (ii) a director or officer for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law; (iii) a director for unlawful payment of dividends or unlawful stock repurchases or redemptions, as provided under Section 174 of the DGCL; (iv) a director or officer for any transaction from which the director or officer derived an improper personal benefit or (v) an officer in any action by or in the right of the corporation. Our certificate of incorporation provides for such limitation of liability.

    Section 145(a) of the DGCL empowers a corporation to indemnify any director, officer, employee or agent, or former director, officer, employee or agent, who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of the corporation), by reason of such person’s service as a director, officer, employee or agent of the corporation, or such person’s service, at the corporation’s request, as a


    director, officer, employee or agent of another corporation or enterprise, against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with such action, suit or proceeding; provided that such director or officer acted in good faith and in a manner reasonably believed to be in or not opposed to the best interests of the corporation; and, with respect to any criminal action or proceeding; provided that such director or officer had no reasonable cause to believe his conduct was unlawful.

    Section 145(b) of the DGCL empowers a corporation to indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the right of the corporation to procure a judgment in its favor by reason of the fact that such person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another enterprise, against expenses (including attorneys’ fees) actually and reasonably incurred in connection with the defense or settlement of such action or suit; provided that such director or officer acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of the corporation, except that no indemnification may be made in respect of any claim, issue or matter as to which such director or officer shall have been adjudged to be liable to the corporation unless and only to the extent that the Delaware Court of Chancery or the court in which such action or suit was brought shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case, such director or officer is fairly and reasonably entitled to indemnity for such expenses that the court shall deem proper. Notwithstanding the preceding sentence, except as otherwise provided in our bylaws, we shall be required to indemnify any such person in connection with a proceeding (or part thereof) commenced by such person only if the commencement of such proceeding (or part thereof) by any such person was authorized by the board of directors.

    In addition, our certificate of incorporation provides that we must indemnify our directors and officers to the fullest extent authorized by law. Under our bylaws, we are also expressly required to advance certain expenses to our directors and officers and we are permitted to, and currently intend to, carry directors’ and officers’ insurance providing indemnification for our directors and officers for some liabilities. We believe that these indemnification provisions and the directors’ and officers’ insurance are useful to attract and retain qualified directors and officers.

    Any underwriting agreements that we may enter into will likely provide for the indemnification of us, our controlling persons, our directors and certain of our officers by the underwriters against certain liabilities, including liabilities under the Securities Act of 1933, as amended.

    Item 16. Exhibits

     

    Exhibit
    Number
      

    Description

    1.1    Form of Underwriting Agreement relating to Class A common stock, preferred stock, depositary shares, warrants, securities purchase contracts and units*
    3.1    Fifth Amended and Restated Certificate of Incorporation of the Company (incorporated herein by reference to the Company’s Current Report on Form 8-K filed by the Company on July 12, 2024)
    3.2    Amended and Restated Bylaws of the Company (incorporated herein by reference to the Company’s Current Report on Form 8-K filed by the Company on April 12, 2023)
    4.1    Form of Certificate of Designation relating to preferred stock*
    4.2    Form of Deposit Agreement, including the form of depositary receipt*
    4.3    Form of Warrant Agreement, including the form of Warrant Certificate*
    4.4    Form of Securities Purchase Contract*
    4.5    Form of Unit Agreement*
    5.1    Opinion of Kirkland & Ellis LLP**


    Exhibit
    Number
      

    Description

    23.1    Consent of Deloitte & Touche LLP
    23.2    Consent of Kirkland & Ellis LLP (included in their opinion filed as Exhibit 5.1)
    24.1    Powers of Attorney (included on signature page)
    107    Filing Fee Table**

     

    *

    To be filed by amendment or incorporated by reference in connection with the offering of the securities.

    **

    Previously filed.

     

    Item 17.

    Undertakings

    The undersigned registrant hereby undertakes:

     

      (1)

    To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

     

      (i)

    To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;

     

      (ii)

    To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the “Calculation of Filing Fee Tables” or “Calculation of Registration Fee” table, as applicable, in the effective registration statement;

     

      (iii)

    To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;

    provided, however, that paragraphs (a)(1)(i), (a)(1)(ii) and (a)(1)(iii) above do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the SEC by the registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement.

     

      (2)

    That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

     

      (3)

    To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

     

      (4)

    That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser:

     

      (i)

    Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and

     

      (ii)

    Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by Section 10(a) of


      the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference in the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date.

     

      (5)

    That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities:

    The undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:

     

      (i)

    Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;

     

      (ii)

    Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;

     

      (iii)

    The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and

     

      (iv)

    Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.

     

      (6)

    The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant’s annual report pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

     

      (7)

    Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the provisions described under Item 15 above, or otherwise, the registrant has been advised that in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act of 1933 and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act of 1933 and will be governed by the final adjudication of such issue.


    SIGNATURES

    Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Plantation, State of Florida, on the 19th day of September, 2024.

     

    CHEWY, INC.
    By:  

    /s/ David Reeder

      David Reeder
      Chief Financial Officer

    POWER OF ATTORNEY

    KNOWN ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints registrant hereby severally constitutes and appoints Da-Wai Hu and David Reeder or either of them acting alone, his or her true and lawful attorney-in-fact and agent, with full power of substitution and revocation, for him or her and in his or her name, place and stead, in any and all capacities, to sign (i) any and all amendments (including post-effective amendments) to this registration statement and to file the same with all exhibits thereto, and other documents in connection therewith and (ii) any registration statement and any and all amendments thereto, relating to the offer covered hereby filed pursuant to Rule 462 under the Securities Act of 1933, with the Securities and Exchange Commission, granting unto said attorney-in fact and agents, full power and authority to do and perform each and every act and thing requisite and necessary to be done as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or his or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

    Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed below by the following persons on the date and in the capacity indicated:

     

    SIGNATURE

      

    TITLE

     

    DATE

    *

    Sumit Singh

      

    Chief Executive Officer and Director

    (Principal Executive Officer)

      September 19, 2024

    /s/ David Reeder

    David Reeder

      

    Chief Financial Officer

    (Principal Financial Officer)

      September 19, 2024

    *

    Raymond Svider

       Chairman of the Board of Directors   September 19, 2024

    *

    Fahim Ahmed

       Director   September 19, 2024

    *

    Mathieu Bigand

       Director   September 19, 2024

    *

    Marco Castelli

       Director   September 19, 2024

    *

    Michael Chang

       Director   September 19, 2024


    SIGNATURE

      

    TITLE

     

    DATE

    *

    Kristine Dickson

       Director   September 19, 2024

    *

    David Leland

       Director   September 19, 2024

    *

    James Nelson

       Director   September 19, 2024

    *

    Martin H. Nesbitt

       Director   September 19, 2024

    *

    Lisa Sibenac

       Director   September 19, 2024

    *

    James A. Star

       Director   September 19, 2024

     

    *By:  

    /s/ David Reeder

      Attorney-in-Fact
    Get the next $CHWY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CHWY

    DatePrice TargetRatingAnalyst
    9/25/2025$48.00Neutral → Buy
    MoffettNathanson
    9/11/2025$47.00Neutral → Buy
    Seaport Research Partners
    9/11/2025$45.00Hold → Buy
    Deutsche Bank
    9/8/2025$50.00Neutral → Outperform
    Mizuho
    7/10/2025Mkt Outperform
    Citizens JMP
    6/9/2025$47.00Outperform → Neutral
    Mizuho
    6/5/2025$43.00Buy → Hold
    Jefferies
    3/24/2025Neutral
    Seaport Research Partners
    More analyst ratings

    $CHWY
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Chewy Inc.

    SCHEDULE 13G/A - Chewy, Inc. (0001766502) (Subject)

    2/10/26 11:21:52 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    SEC Form 8-K filed by Chewy Inc.

    8-K - Chewy, Inc. (0001766502) (Filer)

    1/20/26 7:05:16 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    SEC Form SCHEDULE 13G filed by Chewy Inc.

    SCHEDULE 13G - Chewy, Inc. (0001766502) (Subject)

    12/30/25 6:31:14 PM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    $CHWY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Chewy Announces Third Quarter 2025 Financial Results

    Chewy, Inc. (NYSE:CHWY) ("Chewy"), a trusted destination for pet parents and partners everywhere, has released its financial results for the third quarter of fiscal year 2025 ended November 2, 2025. Fiscal Q3 2025 Highlights: Net sales of $3.12 billion increased 8.3 percent year over year Gross margin of 29.8 percent increased 50 basis points year over year Net income of $59.2 million, including share-based compensation expense and related taxes of $76.5 million Net margin of 1.9 percent increased 180 basis points year over year Basic earnings per share of $0.14, an increase of $0.13 year over year Diluted earnings per share of $0.14, an increase of $0.13 year over year Adjus

    12/10/25 7:05:00 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    Chewy Announces Fiscal Third Quarter 2025 Financial Results Conference Call

    Chewy, Inc. (NYSE:CHWY) ("Chewy"), a trusted destination for pet parents and partners everywhere, announced today that it will report fiscal third quarter 2025 financial results before the market opens on Wednesday, December 10, 2025. Management will host a conference call and webcast to discuss the company's financial results at 8:00 am ET. To access the conference call by phone, please visit this link for registration (Phone Registration Link) to be provided with dial in details, including a unique PIN to access the conference call. To avoid delays, we encourage participants to register in advance or at a minimum 15 minutes before the start of the call. A live audio webcast can be acc

    11/19/25 7:30:00 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    Covetrus Announces Agreement for Chewy to Acquire SmartEquine

    Transaction enables Covetrus to sharpen focus on core business of delivering technology-enabled solutions for veterinarians PORTLAND, Maine, Oct. 30, 2025 /PRNewswire/ -- Covetrus®, a global animal-health technology and services company, today announced that it has entered into a definitive agreement with Chewy, Inc. (NYSE:CHWY) for Chewy to acquire the SmartEquine® business. This transaction enables Covetrus to sharpen its focus on its core business of delivering technology-enabled solutions that help veterinarians improve practice performance and patient care. By concentrati

    10/30/25 11:48:00 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    $CHWY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Chewy upgraded by MoffettNathanson with a new price target

    MoffettNathanson upgraded Chewy from Neutral to Buy and set a new price target of $48.00

    9/25/25 8:21:50 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    Chewy upgraded by Seaport Research Partners with a new price target

    Seaport Research Partners upgraded Chewy from Neutral to Buy and set a new price target of $47.00

    9/11/25 8:35:47 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    Chewy upgraded by Deutsche Bank with a new price target

    Deutsche Bank upgraded Chewy from Hold to Buy and set a new price target of $45.00

    9/11/25 8:34:30 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    $CHWY
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 14, 2023 - FDA Warns Nine Manufacturers, Distributors of Unapproved Antimicrobials for Animals

    For Immediate Release: December 14, 2023 Today, the U.S. Food and Drug Administration is announcing the issuance of nine warning letters to manufacturers and distributors of unapproved and misbranded antimicrobial animal drugs for violations of federal law. The agency is concerned because these products contain antimicrobials that are important in human medicine and using them without medical oversight contribut

    12/14/23 9:00:20 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    $CHWY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Accounting Officer Billings William G. covered exercise/tax liability with 1,207 shares, decreasing direct ownership by 4% to 32,540 units (SEC Form 4)

    4 - Chewy, Inc. (0001766502) (Issuer)

    2/3/26 5:59:21 PM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    Chief Technology Officer Mehta Satish covered exercise/tax liability with 29,243 shares and sold $377,247 worth of shares (13,013 units at $28.99), decreasing direct ownership by 9% to 273,835 units (SEC Form 4)

    4 - Chewy, Inc. (0001766502) (Issuer)

    2/3/26 5:58:02 PM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    Chief Executive Officer Singh Sumit covered exercise/tax liability with 180,308 shares, decreasing direct ownership by 16% to 886,890 units (SEC Form 4)

    4 - Chewy, Inc. (0001766502) (Issuer)

    2/3/26 5:55:57 PM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    $CHWY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Star James A bought $249,519 worth of shares (12,242 units at $20.38), increasing direct ownership by 9% to 141,790 units (SEC Form 4)

    4 - Chewy, Inc. (0001766502) (Issuer)

    12/18/23 4:09:39 PM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    Star James A bought $300,992 worth of shares (15,353 units at $19.60), increasing direct ownership by 13% to 129,548 units (SEC Form 4)

    4 - Chewy, Inc. (0001766502) (Issuer)

    12/14/23 4:10:59 PM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    $CHWY
    Financials

    Live finance-specific insights

    View All

    Chewy Announces Third Quarter 2025 Financial Results

    Chewy, Inc. (NYSE:CHWY) ("Chewy"), a trusted destination for pet parents and partners everywhere, has released its financial results for the third quarter of fiscal year 2025 ended November 2, 2025. Fiscal Q3 2025 Highlights: Net sales of $3.12 billion increased 8.3 percent year over year Gross margin of 29.8 percent increased 50 basis points year over year Net income of $59.2 million, including share-based compensation expense and related taxes of $76.5 million Net margin of 1.9 percent increased 180 basis points year over year Basic earnings per share of $0.14, an increase of $0.13 year over year Diluted earnings per share of $0.14, an increase of $0.13 year over year Adjus

    12/10/25 7:05:00 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    Chewy Announces Fiscal Third Quarter 2025 Financial Results Conference Call

    Chewy, Inc. (NYSE:CHWY) ("Chewy"), a trusted destination for pet parents and partners everywhere, announced today that it will report fiscal third quarter 2025 financial results before the market opens on Wednesday, December 10, 2025. Management will host a conference call and webcast to discuss the company's financial results at 8:00 am ET. To access the conference call by phone, please visit this link for registration (Phone Registration Link) to be provided with dial in details, including a unique PIN to access the conference call. To avoid delays, we encourage participants to register in advance or at a minimum 15 minutes before the start of the call. A live audio webcast can be acc

    11/19/25 7:30:00 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    Chewy Announces Second Quarter 2025 Financial Results

    Chewy, Inc. (NYSE:CHWY) ("Chewy"), a trusted destination for pet parents and partners everywhere, has released its financial results for the second quarter of fiscal year 2025 ended August 3, 2025. Fiscal Q2 2025 Highlights: Net sales of $3.10 billion increased 8.6 percent year over year Gross margin of 30.4 percent increased 90 basis points year over year Net income of $62.0 million, including share-based compensation expense and related taxes of $79.1 million Net margin of 2.0 percent decreased 850 basis points year over year(2) Basic earnings per share of $0.15, a decrease of $0.55 year over year(2) Diluted earnings per share of $0.14, a decrease of $0.54 year over ye

    9/10/25 7:05:00 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    $CHWY
    Leadership Updates

    Live Leadership Updates

    View All

    Chewy Set to Join S&P MidCap 400

    NEW YORK, Nov. 1, 2024 /PRNewswire/ -- Chewy Inc. (NYSE: CHWY) will replace Stericycle Inc. (NASD: SRCL) in the S&P MidCap 400 effective prior to the opening of trading on Wednesday, November 6. S&P 500 constituent Waste Management Inc. (NYSE:WM) is acquiring Stericycle in a deal expected to be completed soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector November 6, 2024 S&P MidCap 400 Addition Chewy CHWY Consumer Discretionary November 6, 2024 S&P MidCap 400 Deletion Stericycle SRCL Industrial For more information about

    11/1/24 7:11:00 PM ET
    $CHWY
    $SPGI
    $SRCL
    Catalog/Specialty Distribution
    Consumer Discretionary
    Finance: Consumer Services
    Finance

    Chewy Appoints Mark Eamer as Chief Marketing Officer

    Seasoned Leader to Spearhead Continued Expansion of Chewy's Marketing and Customer Engagement Capabilities Chewy, Inc. ("Chewy") (NYSE:CHWY), a leading online destination for pet parents and partners, announced today the appointment of Mark Eamer as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210930005601/en/Chewy Appoints Mark Eamer as Chief Marketing Officer (Photo: Business Wire) As CMO, Mark will spearhead the continued expansion of Chewy's Marketing and Customer Engagement capabilities, with ownership of the company's marketing strategy, partnerships and analytics, including full funnel cus

    9/30/21 9:00:00 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    GameStop Announces Additional Board Refreshment to Accelerate Transformation

    Aligns with Ryan Cohen of RC Ventures on the Immediate Appointment of Three New Directors with Significant E-Commerce and Technology Experience Confirms the Board’s Commitment to Supporting GameStop’s Pursuit of Growth and Market Leadership GRAPEVINE, Texas, Jan. 11, 2021 (GLOBE NEWSWIRE) -- GameStop Corp. (NYSE: GME) (“GameStop” or the “Company”) today announced that it has entered into an agreement with RC Ventures LLC (“RC Ventures”) that will advance the refreshment of the Company’s Board of Directors (the “Board”). RC Ventures, which is one of the Company’s largest stockholders, is managed by Ryan Cohen. The agreement provides for the immediate appointment of three new directors –

    1/11/21 7:30:00 AM ET
    $CHWY
    $GME
    Catalog/Specialty Distribution
    Consumer Discretionary
    Electronics Distribution

    $CHWY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Chewy Inc.

    SC 13G/A - Chewy, Inc. (0001766502) (Subject)

    11/12/24 2:29:11 PM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Chewy Inc.

    SC 13G/A - Chewy, Inc. (0001766502) (Subject)

    11/6/24 4:39:56 PM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Chewy Inc.

    SC 13G/A - Chewy, Inc. (0001766502) (Subject)

    11/4/24 11:23:07 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary